Biochemistry and Genetics Pretesttmself-Assessment and Review Notice
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Phosphorylation of Mcardle Phosphorylase Induces Activity (Human Skeletal Muscle/Protein Kinase) CESARE G
Proc. Nati. Acad. Sci. USA Vol. 78, No. 5, pp. 2688-2692, May 1981 Biochemistry Phosphorylation of McArdle phosphorylase induces activity (human skeletal muscle/protein kinase) CESARE G. CERRI AND JOSEPH H. WILLNER Department of Neurology and H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Columbia University College of Physicians and Surgeons, New York, New York 10032 Communicated by Harry Grundfest, January 7, 1981 ABSTRACT In McArdle disease, myophosphorylase defi- mediate between those of phosphorylases b and a. Karpatkin ciency, enzyme activity is absent but the presence of an altered et al. (19, 20) found that incubation of human platelets with enzyme protein can frequently be demonstrated. We have found MgATP+ resulted in an increase in total phosphorylase activity that phosphorylation of this protein in vitro can result in catalytic and concluded that the data were "consistent with the presence activity. We studied muscle of four patients; all lacked myophos- in human platelets of inactive dimer and monomer species of phorylase activity, but myophosphorylase protein was demon- phosphorylase, which require MgATP for activation." Because strated by immunodiffusion or gel electrophoresis. Incubation of activation of these isozymes was probably due to protein phos- muscle homogenate supernatants with cyclic AMP-dependent pro- phorylation and also because incomplete phosphorylation could tein kinase and ATP resulted in phosphorylase activity. The ac- tivated enzyme comigrated with normal human myophosphory- result in reduced activity, we evaluated the possibility that the lase in gel electrophoresis. Incubation with [y-32P]ATP resulted activity ofphosphorylase in McArdle muscle could be restored in incorporation of 32P into the band possessing phosphorylase by phosphorylation of the inactive phosphorylase protein pres- activity. -
Enzymatic Encoding Methods for Efficient Synthesis Of
(19) TZZ__T (11) EP 1 957 644 B1 (12) EUROPEAN PATENT SPECIFICATION (45) Date of publication and mention (51) Int Cl.: of the grant of the patent: C12N 15/10 (2006.01) C12Q 1/68 (2006.01) 01.12.2010 Bulletin 2010/48 C40B 40/06 (2006.01) C40B 50/06 (2006.01) (21) Application number: 06818144.5 (86) International application number: PCT/DK2006/000685 (22) Date of filing: 01.12.2006 (87) International publication number: WO 2007/062664 (07.06.2007 Gazette 2007/23) (54) ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES ENZYMVERMITTELNDE KODIERUNGSMETHODEN FÜR EINE EFFIZIENTE SYNTHESE VON GROSSEN BIBLIOTHEKEN PROCEDES DE CODAGE ENZYMATIQUE DESTINES A LA SYNTHESE EFFICACE DE BIBLIOTHEQUES IMPORTANTES (84) Designated Contracting States: • GOLDBECH, Anne AT BE BG CH CY CZ DE DK EE ES FI FR GB GR DK-2200 Copenhagen N (DK) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • DE LEON, Daen SK TR DK-2300 Copenhagen S (DK) Designated Extension States: • KALDOR, Ditte Kievsmose AL BA HR MK RS DK-2880 Bagsvaerd (DK) • SLØK, Frank Abilgaard (30) Priority: 01.12.2005 DK 200501704 DK-3450 Allerød (DK) 02.12.2005 US 741490 P • HUSEMOEN, Birgitte Nystrup DK-2500 Valby (DK) (43) Date of publication of application: • DOLBERG, Johannes 20.08.2008 Bulletin 2008/34 DK-1674 Copenhagen V (DK) • JENSEN, Kim Birkebæk (73) Proprietor: Nuevolution A/S DK-2610 Rødovre (DK) 2100 Copenhagen 0 (DK) • PETERSEN, Lene DK-2100 Copenhagen Ø (DK) (72) Inventors: • NØRREGAARD-MADSEN, Mads • FRANCH, Thomas DK-3460 Birkerød (DK) DK-3070 Snekkersten (DK) • GODSKESEN, -
Statistical Mechanics of Allosteric Enzymes
Statistical Mechanics of Allosteric Enzymes Tal Einav,† Linas Mazutis,‡ and Rob Phillips∗,¶ Department of Physics, California Institute of Technology, Pasadena, California 91125, United States, Institute of Biotechnology, Vilnius University, Vilnius, Lithuania, and Department of Applied Physics and Division of Biology, California Institute of Technology, Pasadena, California 91125, United States E-mail: [email protected] Abstract The concept of allostery in which macromolecules switch between two different conforma- tions is a central theme in biological processes ranging from gene regulation to cell signaling to enzymology. Allosteric enzymes pervade metabolic processes, yet a simple and unified treatment of the effects of allostery in enzymes has been lacking. In this work, we take the first step towards this goal by modeling allosteric enzymes and their interaction with two key molecular players - allosteric regulators and competitive inhibitors. We then apply this model to characterize existing data on enzyme activity, comment on how enzyme parameters (such as substrate binding affinity) can be experimentally tuned, and make novel predictions on how to control phenomena such as substrate inhibition. arXiv:1701.03988v1 [q-bio.SC] 15 Jan 2017 ∗To whom correspondence should be addressed †Department of Physics, California Institute of Technology, Pasadena, California 91125, United States ‡Institute of Biotechnology, Vilnius University, Vilnius, Lithuania ¶Department of Applied Physics and Division of Biology, California Institute -
Lec-08-Handout
NPTEL VIDEO COURSE – PROTEOMICS PROF. SANJEEVA SRIVASTAVA HANDOUT LECTURE-08 ENZYME: BASIC CONCEPTS, CATALYTIC AND REGULATORY STRATEGIES Slide 1 Today, we will talk about enzyme: basic concepts, catalytic and regulatory strategies. Slide 2 Lecture outline: • Basic concepts of enzyme including enzyme kinetics, energetics and enzyme inhibition. • Different type of catalytic strategies and regulatory strategies. Slide 3 So as you all know, enzymes play very important role in biochemistry All enzymes are proteins therefore it will essential to study about enzymes while studying basic concepts of amino acids and proteins. Although it may not be directly linked to the proteomics but understanding of enzyme and proteins is very fundamental for the advanced understanding of concepts related to proteomics. Slide 4 So what are enzymes? • Enzymes are molecular catalysts. • Almost all enzymes are proteins and as we have discussed in the previous lecture there are twenty amino acids that make up the basic building blocks of all proteins. • Enzymes can accelerate a given reaction up to million folds. Let’s take an example of carbonic anhydrase which catalyzes hydration of carbon di oxide. Now this enzyme can catalyze 106 molecules per second. • Enzymes are highly specific and catalyze single or closely related reaction. DEPARTMENT OF BIOSCIENCES & BIOENGINEERING INDIAN INSTITUTE OF TECHNOLOGY (IIT) BOMBAY, MUMBAI, INDIA Page 1 NPTEL VIDEO COURSE – PROTEOMICS PROF. SANJEEVA SRIVASTAVA Slide 5 In terms of enzyme specificity, let me give you few examples- • Trypsin- it is highly specific, it cleaves peptide on carboxyl side of Lys/Arg. • Another enzyme thrombin, which participates in blood clotting, it is even more specific that trypsin. -
Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide
ICANCER RESEARCH 26 Part 1, 1466-1472,July 1966] Deoxyribonucleic Acid Synthesis I. Effect of in Vivo Cyclophosphamide Treatment on the in Vitro Activity of the Deoxyribonucleic Acid Synthetase System of Sensitive and Resistant Plasmacytomas1 ARTHUR J. TOMISEK, MARTHA BRUCE IRICK, AND PAULA WEDELES ALLAN Kettering'-Meyer Laboratory,2 Southern Research Institute, Birmingham, Alabama Summary term DNA-synthetase. In addition to this measurement of over-all DNA synthetase activity, we used the same experiments We have shown that the in vivo treatment of Fortner plasma- to determine the time course of radioactivity distribution among cytomas with Cyclophosphamide can lead to strong inhibitions of both deoxyribonucleic acid nucleotidyl transferase and thymi- the soluble components of the synthetase reaction mixtures. Our data show that the observed decreases in enzyme activity dylatc kinase activities in the soluble cell fractions. However, in are among the possible consequences of growth inhibition in the allowing only 2 hr for the inhibitor to act, the effect observed on tumor. the transferase was an unexplained stimulation rather than an inhibition. We have also provided some evidence that the inhibition of Materials and Methods growth precedes the inhibition of deoxyribonucleic acid nucleo ENZYME PREPARATION.Fortner hamster plasmacytoma tidyl transferase activity. ("sensitive") (3) and ite cyclophosphamide-resistant subline (12) were used for bilateral s.c. implantation into groups of 6-12 Introduction Golden Syrian hamsters, the animals in each experiment being uniform with respect to commercial subline, sex, and approxi Previous studies in this laboratory have shown that several mate age. On the 12th-14th postimplant day the animals were alkylating agents inhibited the in vivo synthesis of DNA by divided into 2 subgroups, to receive daily i.p. -
WO 2013/153359 Al 17 October 2013 (17.10.2013) P O P C T
(12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2013/153359 Al 17 October 2013 (17.10.2013) P O P C T (51) International Patent Classification: Edmund Cartwright House, 4 Robert Robinson Avenue, C07K 14/435 (2006.01) C12Q 1/00 (2006.01) Oxford Science Park, Oxford Oxfordshire OX4 4GA (GB). (21) International Application Number: (74) Agent: CHAPMAN, Lee Phillip; 14 South Square, Gray's PCT/GB20 13/050667 Inn, London Greater London WC1R 5JJ (GB). (22) International Filing Date: (81) Designated States (unless otherwise indicated, for every 15 March 2013 (15.03.2013) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, (25) Filing Language: English BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (26) Publication Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, (30) Priority Data: KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, 61/622,174 10 April 2012 (10.04.2012) US ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, (71) Applicant: OXFORD NANOPORE TECHNOLOGIES NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, LIMITED [GB/GB]; Edmund Cartwright House, 4 Robert RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, Robinson Avenue, Oxford Science Park, Oxford Oxford TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, shire OX4 4GA (GB). -
(Glycogen Storage Disease Type V) and Anesthesia a Case Report And
Pediatric Anesthesia ISSN 1155-5645 REVIEW ARTICLE McArdle’s disease (glycogen storage disease type V) and anesthesia – a case report and review of the literature Georg Bollig1,2 1 Department of Anesthesiology and Intensive Care, Palliative Medicine and Pain Therapy, HELIOS Klinikum Schleswig, Schleswig, Germany 2 Department of Surgical Sciences, Haukeland University Hospital, University of Bergen, Bergen, Norway Keywords Summary general anesthesia; glycogen storage disease; glycogen storage disease type V; McArdles disease (glycogen storage disease type v) is a rare condition in malignant hyperthermia; McArdles disease; which energy-metabolism in the muscle is hampered. A case report is pre- perioperative complications sented and the possible risk for perioperative complications including malig- nant hyperthermia is discussed. A checklist for the anesthesiological Correspondence management of patients with McArdles disease is provided. A short overview Georg Bollig, Department of Anesthesiology of anesthesiological challenges and perioperative complications of other gly- and Intensive Care, Palliative Medicine and Pain Therapy, HELIOS Klinikum Schleswig, cogen storage diseases is given. Schleswig, Germany Email: [email protected] Section Editor: Barbara Brandom Accepted 3 March 2013 doi:10.1111/pan.12164 tachycardia and hypotonia occurred. After the opera- Introduction tion, the anesthesiologist informed the patient about the McArdle’s disease is a rare condition in which energy event and the fact that he had elevated liver enzymes metabolism in the muscle is hampered. A case report (aspartate transaminase = AST, alanine transaminase = will be presented, and the possible risk of perioperative ALT, and lactate dehydrogenase = LDH). An overview problems including malignant hyperthermia is dis- of the patient’s anesthesiological history is given in cussed. -
Hemoglobin : Its Protein of Molecular Weight 64,450 , in Human Beings It
Hemoglobin : its protein of molecular weight 64,450 , in human beings it is enclose in the RBC .if it were in plasma, some of it leaks through the capillary membrane into the tissue space or through the glomerular membrane of the kidney into the glomerular filtrate each time the blood passes through the capillaries , high free plasma concentration of Hb increased blood viscosity and osmotic pressure. So for Hb to remain in the bloodstream , it must exist in the RBCs ,its major function is to carry O2 to the tissue and also it transport CO2 from the tissues to the lungs Normal hemoglobin type: Hb A: Its normal adult Hb . Its molecule consist of four polypeptide chains ,2 alpha (α) chains (each of which contains 141 amino acids) and 2 beta chains (each of which contains 146 amino acids).thus Hb A is designated α2 and β2. Hb A is predominant type of Hb in adult (95- 97% of total Hb) . Hb A2 : in the normal adult about 25% of the total Hb is Hb A2 in which chain are replaced by delta chains and is designated 2 α 2δ2 . Each δ chain also contain 146 amino acid but 10 amino acid differ from those in the β chain . Hb F (Fetal Hb): it is the main Hb in fetus and new born . It is 2α 2γ,gamma(γ) chain also has 146 amino acid but 37 amino acid differ from those in β chain, Hb F is replaced gradually by adult Hb soon after birth, usually at about 6 months to one year of age, the normal adult Hb predominates . -
Metabolic Stable Isotope Fractionation
Photograph by author, Gina M.A. Carroll Metabolic Stable Isotope Fractionation: Biogeochemical Approaches to Diagnosing Sickle Cell and Thalassemia Anemia in the Archaeological Record MSc Thesis Faculty of Archaeology MSc Proefschrift Faculteit der Archaeologie Gina M.A. Carroll 1 Photograph by Gina. M.A. Carroll Taken with permission from the Municipal Museum of Écija, Spain April 2014 Gina M.A. Carroll Alberta, Canada Leiden, The Netherlands [email protected] 1 Metabolic Stable Isotope Fractionation: Biogeochemical Approaches to Diagnosing Sickle Cell and Thalassemia Anemia in the Archaeological Record. MSc Thesis MSc Proefschrift Gina M.A. Carroll Human Osteology and Funerary s1371266 Archaeology MSc Thesis Archaeology University of Leiden Faculty of Archaeology ARCH 1044WY Prof. Dr. Waters-Rist Leiden, The Netherlands & Prof. Dr. Inskip Leiden, 26 May 2015 Final Draft. 2 TABLE OF CONTENTS DEDICATIONS ...................................................................................................................... 9 ACKNOWLEDGEMENTS .................................................................................................. 10 CHAPTER 1 INTRODUCTION ....................................................................... 12-30 1. BRIEF HISTORY OF ARCHAEOLOGICAL RESEARCH ........................................ 13 1.1. The Anemias in Archaeology ....................................................... 14 1.2. The Application of Stable Isotopes in Palaeopathology ............... 18 2. HYPOTHESIS ................................................................................................ -
Structure and Evolution of Protein Allosteric Sites
Structure and evolution of protein allosteric sites by Alejandro Panjkovich Thesis submitted to Universitat Aut`onoma de Barcelona in partial fulfillment of the requirements for the degree of Doctor of Philosophy Director - Prof. Xavier Daura Tesi Doctoral UAB/ANY 2013 Ph.D. Program - Protein Structure and Function Institut de Biotecnologia i Biomedicina caminante, no hay camino, se hace camino al andar Antonio Machado,1912 Acknowledgements First of all I would like to thank my supervisor and mentor Prof. Xavier Daura for his consistent support and trust in my work throughout these years. Xavi, I deeply appreciate the freedom you gave me to develop this project while you were still carefully aware of the small details. Working under your supervision has been a rich and fulfilling experience. Of course, thanks go as well to current and past members of our institute, especially Rita Rocha, Pau Marc Mu˜noz,Oscar Conchillo, Dr. Mart´ınIndarte, Dr. Mario Ferrer, Prof. Isidre Gibert, Dr. Roman Affentranger and Dr. Juan Cedano for their technical and sometimes philo- sophical assistance. Help from the administrative staff was also significant, I would like to thank in particular Eva, Alicia and Miguel who where always ready to help me in sorting out unexpected bureaucratic affairs. I would also like to thank Dr. Mallur Srivatasan Madhusudhan and his group (especially Kuan Pern Tan, Dr. Minh Nguyen and Binh Nguyen), and also Dr. Gloria Fuentes, Cassio Fernandes, Youssef Zaki, Thijs Kooi, Rama Iyer, Christine Low and many others at the Bioinformatics Institute BII - A∗STAR in Singapore for the many interesting discussions and support during my stage over there. -
Guaiacol As a Drug Candidate for Treating Adult Polyglucosan Body Disease
Guaiacol as a drug candidate for treating adult polyglucosan body disease Or Kakhlon, … , Wyatt W. Yue, H. Orhan Akman JCI Insight. 2018;3(17):e99694. https://doi.org/10.1172/jci.insight.99694. Research Article Metabolism Therapeutics Graphical abstract Find the latest version: https://jci.me/99694/pdf RESEARCH ARTICLE Guaiacol as a drug candidate for treating adult polyglucosan body disease Or Kakhlon,1 Igor Ferreira,2 Leonardo J. Solmesky,3 Netaly Khazanov,4 Alexander Lossos,1 Rafael Alvarez,5 Deniz Yetil,6 Sergey Pampou,7 Miguel Weil,3,8 Hanoch Senderowitz,4 Pablo Escriba,5 Wyatt W. Yue,2 and H. Orhan Akman9 1Department of Neurology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. 2Structural Genomics Consortium, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.3 Cell Screening Facility for Personalized Medicine, Department of Cell Research and Immunology, The George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel. 4Department of Chemistry, Bar Ilan University, Ramat Gan, Israel. 5Laboratory of Molecular Cell Biomedicine, Department of Biology, University of the Balearic Islands, Palma de Mallorca, Spain. 6Connecticut College, Newington, Connecticut USA. 7Columbia University Department of Systems Biology Irving Cancer Research Center, New York, New York, USA. 8Laboratory for Neurodegenerative Diseases and Personalized Medicine, Department of Cell Research and Immunology, The George S. Wise Faculty for Life Sciences, Sagol School of Neurosciences, Tel Aviv University, Ramat Aviv, Tel Aviv, Israel. 9Columbia University Medical Center Department of Neurology, Houston Merritt Neuromuscular diseases research center, New York, New York, USA. Adult polyglucosan body disease (APBD) is a late-onset disease caused by intracellular accumulation of polyglucosan bodies, formed due to glycogen-branching enzyme (GBE) deficiency. -
Published on May 14, 2008 As Doi: 10.1183/09031936.00126507 ERJ
ERJ Express. Published on May 14, 2008 as doi: 10.1183/09031936.00126507 ACCURACY AND RELIABILITY OF PULSE OXIMETRY AT DIFFERENT PaCO2 LEVELS Authors: Muñoz Xa,b,d , Torres Fc , Sampol Ga,d , Rios Jc , Martí Sa,d , Escrich Eb a) Servei de Pneumologia,Hospital Universitari Vall d’Hebron, Barcelona, Spain b) Departament de Biología Cel·lular, de Fisiologia i d’Immunologia, UAB, Barcelona, Spain c) Laboratorio de Bioestadística i Epidemiología (Universitat Autònoma de Barcelona); Servei de Farmacologia Clínica, IDIBAPS, (Hospital Clínic), Barcelona d) CIBER de Enfermedades Respiratorias (Ciberes) Correspondence to: Dr. Xavier Muñoz Servei de Pneumologia Hospital Vall d'Hebron Pº Vall d'Hebron, 119-129 08035 Barcelona Spain Telf: 00 34 93 2746157 Fax: 00 34 93 2746083 E-mail: [email protected] Short title: ACCURACY OF PULSE OXIMETRY AND PaCO2 LEVELS The first two authors have contributed equally to this study. Copyright 2008 by the European Respiratory Society. ABSTRACT Aim: To assess whether arterial carbon dioxide pressure (PaCO2) has an impact on agreement between oxygen saturation measured with pulse oximetry (SpO2) or arterial blood gas co- oximetry (SaO2). Methods: A study was performed on SaO2 and SpO2 determinations obtained simultaneously from 846 patients under assessment for long-term home oxygen therapy in a specialized outpatient clinic. Both measurements were taken with patients seated and breathing room air. Agreement between SaO2 and SpO2 results was analyzed by the Bland-Altman method and the Lin concordance coefficient. In addition, potential interactions of PaO2 or PaCO2 on agreement were analyzed by adjusted multivariate analysis. Results: At comparison of SaO2 and SpO2 results, the Bland-Altman technique yielded a bias (95% CI) of -1.24 (-6.86; 4.38) and -1.32 (-7.78; 5.15) when PaCO2 was higher than 48 mmHg or PaO2 lower than 54 mmHg, respectively.